4/A: Rezolute Inc. Chief Medical Officer Reports Amended Transaction: Minor Child's Holdings Corrected
SEC Filing
Brian Kenneth Roberts, Chief Medical Officer of Rezolute, Inc., files an amended Form 4 to correct the reported indirect holdings of common shares held by his minor child.
Summary
- Brian Kenneth Roberts, the Chief Medical Officer of Rezolute, Inc. [RZLT], filed an amended Form 4 with the SEC.
- The amendment corrects the total indirect holdings of common shares held by his minor child.
- On March 7, 2024, Roberts acquired 500 common shares at a price of $1.85 per share.
- Following the reported transaction, Roberts directly owns 42,552 common shares.
- The filing indicates that Roberts indirectly owns 576 common shares through a minor child.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Industry Context
This is a routine disclosure related to insider trading and holdings, and doesn't necessarily reflect on the broader pharmaceutical industry or Rezolute's competitive position.
Key Dates
| Date | Description |
|---|---|
| 03/07/2024 | Date of the transaction where 500 common shares were acquired. |
| 03/08/2024 | Date of signature on the amended form. |
| 03/11/2024 | Date of original filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.